Antoinette R. Tan, MD, MHSc, FACP | Authors


Immune Checkpoint Blockade: A New Strategy for the Treatment of Breast Cancer

July 13, 2016

Breast cancer has traditionally not been viewed as immunogenic. There is now a growing body of evidence that immune infiltration has a prognostic role in al breast cancer subtypes, and predicts improved clinical outcome in triple-negative and human epidermal growth factor receptor 2-positive tumors.